We present a case of an 89-year-old male diagnosed with a prostatic adenocarcinoma.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
He developed a metastasis to his left testis and was treated with bilateral orchiectomy. Histology showed a ductal adenocarcinoma with positive immunohistochemical markers for PSA and p501. Testicular metastases from prostate cancer are rare and are assumed to be associated with progressed disease and poor prognosis. Ductal adenocarcinomas may be associated with a higher risk of dissemination to the testis.
Mortensen MA, Engvad B, Geertsen L, Svolgaard N, Lund L. Are you the author?
Urologisk Afdeling L, Odense Universitetshospital, Sdr. Boulevard 29, 5000 Odense.
Reference: Ugeskr Laeger. 2014 Mar 24;176(13). pii: V10130632.
Article in Danish.